Leclercq Tamara M, Pitson Stuart M
Hanson Institute, Division of Human Immunology, Institute of Medical and Veterinary Science, Adelaide, Australia.
IUBMB Life. 2006 Aug;58(8):467-72. doi: 10.1080/15216540600871126.
Sphingosine kinases, through the formation of the bioactive phospholipid sphingosine 1-phosphate, have been implicated in a diverse range of cellular processes, including cell proliferation, apoptosis, calcium homeostasis, angiogenesis and vascular maturation. The last few years have seen a number of significant advances in understanding of the mechanisms of action, activation, cellular localisation and biological roles of these enzymes. Here we review the current understanding of the regulation of and cellular signalling by sphingosine kinase and sphingosine 1-phosphate and discuss recent findings implicating sphingosine kinase as a potential therapeutic target for the control of cancer, inflammation and a number of other diseases. We suggest that, since the activation and subcellular localization of these enzymes appear to play critical roles in their biological functions, targeting these processes may provide more specific therapeutic options than direct catalytic inhibitors.
鞘氨醇激酶通过形成生物活性磷脂鞘氨醇-1-磷酸,参与了多种细胞过程,包括细胞增殖、凋亡、钙稳态、血管生成和血管成熟。在过去几年中,人们对这些酶的作用机制、激活、细胞定位和生物学作用的理解取得了许多重大进展。在此,我们综述了目前对鞘氨醇激酶和鞘氨醇-1-磷酸的调节及细胞信号传导的认识,并讨论了最近的研究结果,这些结果表明鞘氨醇激酶作为控制癌症、炎症和许多其他疾病的潜在治疗靶点。我们认为,由于这些酶的激活和亚细胞定位似乎在其生物学功能中起关键作用,针对这些过程可能比直接的催化抑制剂提供更具特异性的治疗选择。